"Calcineurin Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that inhibit or block the PHOSPHATASE activity of CALCINEURIN.
| Descriptor ID |
D065095
|
| MeSH Number(s) |
D27.505.519.389.174
|
| Concept/Terms |
Calcineurin Inhibitors- Calcineurin Inhibitors
- Protein Phosphatase-2B Inhibitors
- Protein Phosphatase 2B Inhibitors
- Protein Phosphatase 3 Inhibitors
- Calcineurin Antagonists
- Calcineurin Blockers
|
Below are MeSH descriptors whose meaning is more general than "Calcineurin Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Calcineurin Inhibitors".
This graph shows the total number of publications written about "Calcineurin Inhibitors" by people in this website by year, and whether "Calcineurin Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 4 | 4 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 2 | 3 |
| 2018 | 0 | 1 | 1 |
| 2019 | 2 | 0 | 2 |
| 2022 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Calcineurin Inhibitors" by people in Profiles.
-
Zorzetti N, Lauro A, Khouzam S, Marino IR. Immunosuppression, Compliance, and Tolerance After Orthotopic Liver Transplantation: State of the Art. Exp Clin Transplant. 2022 03; 20(Suppl 1):3-9.
-
Hissong E, Mostyka M, Yantiss RK. Histologic Features of Tacrolimus-induced Colonic Injury. Am J Surg Pathol. 2022 01 01; 46(1):118-123.
-
Konda P, Golamari R, Eisen HJ. Novel Immunosuppression in Solid Organ Transplantation. Handb Exp Pharmacol. 2022; 272:267-285.
-
Tsay AJ, Eisen HJ. mTOR inhibitors vs calcineurin inhibitors: A Catch-22-preventing nephrotoxicity or acute allograft rejection after heart transplantation. Am J Transplant. 2019 11; 19(11):2967-2968.
-
Lam E, Bashir B, Chaballa M, Kraft WK. Drug interactions between direct-acting oral anticoagulants and calcineurin inhibitors during solid organ transplantation: considerations for therapy. Expert Rev Clin Pharmacol. 2019 Aug; 12(8):781-790.
-
Tziotzios C, Brier T, Lee JYW, Saito R, Hsu CK, Bhargava K, Stefanato CM, Fenton DA, McGrath JA. Lichen planus and lichenoid dermatoses: Conventional and emerging therapeutic strategies. J Am Acad Dermatol. 2018 Nov; 79(5):807-818.
-
Cheney-Peters D, Lund TC. Oral Pyogenic Granuloma After Bone Marrow Transplant in the Pediatric/Adolescent Population: Report of 5 Cases. J Pediatr Hematol Oncol. 2016 10; 38(7):570-3.
-
Sieg A, Weeks P, Krustchinsky L, Rajapreyar I. Statin therapy in cardiac allograft vasculopathy progression in heart transplant patients: Does potency matter? Transplant Rev (Orlando). 2016 07; 30(3):178-86.
-
Timofte I, Terrin M, Barr E, Sanchez P, Kim J, Reed R, Britt E, Ravichandran B, Rajagopal K, Griffith B, Pham S, Pierson RN, Iacono A. Belatacept for renal rescue in lung transplant patients. Transpl Int. 2016 Apr; 29(4):453-63.
-
Patel A, Knorr JP, Campos S, Khanmoradi K, Zaki RF, Bradauskaite G. De Novo Thrombotic Microangiopathy Immediately After Kidney Transplant in Patients Without Apparent Risk Factors. Exp Clin Transplant. 2016 Apr; 14(2):230-4.